These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7816248)

  • 1. Trends in incidence of end-stage renal failure in Australia, 1972-1991.
    Stewart JH; McCredie M; Disney AP; Mathew TH
    Nephrol Dial Transplant; 1994; 9(10):1377-82. PubMed ID: 7816248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Geographic, ethnic, age-related and temporal variation in the incidence of end-stage renal disease in Europe, Canada and the Asia-Pacific region, 1998-2002.
    ; Stewart JH; McCredie MR; Williams SM
    Nephrol Dial Transplant; 2006 Aug; 21(8):2178-83. PubMed ID: 16595584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in incidence of end-stage renal disease in Japan, 1983-2000: age-adjusted and age-specific rates by gender and cause.
    Wakai K; Nakai S; Kikuchi K; Iseki K; Miwa N; Masakane I; Wada A; Shinzato T; Nagura Y; Akiba T
    Nephrol Dial Transplant; 2004 Aug; 19(8):2044-52. PubMed ID: 15173379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ESRD in Australia and New Zealand at the end of the millennium: a report from the ANZDATA registry.
    McDonald SP; Russ GR; Kerr PG; Collins JF;
    Am J Kidney Dis; 2002 Dec; 40(6):1122-31. PubMed ID: 12460029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in incidence of treated end-stage renal disease, overall and by primary renal disease, in persons aged 20-64 years in Europe, Canada and the Asia-Pacific region, 1998-2002.
    Stewart JH; McCredie MR; Williams SM; Jager KJ; Trpeski L; McDonald SP;
    Nephrology (Carlton); 2007 Oct; 12(5):520-7. PubMed ID: 17803478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-related differences in susceptibility of males and females to end-stage reflux nephropathy.
    Stewart JH; Hodson EM
    Clin Nephrol; 1995 Mar; 43(3):165-8. PubMed ID: 7774072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of end-stage renal disease in overseas-born, compared with Australian-born, non-indigenous Australians.
    Stewart JH; McCredie MR; McDonald SP
    Nephrology (Carlton); 2004 Aug; 9(4):247-52. PubMed ID: 15363057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal cell and transitional cell carcinoma in a Japanese population undergoing maintenance dialysis.
    Satoh S; Tsuchiya N; Habuchi T; Ishiyama T; Seimo K; Kato T
    J Urol; 2005 Nov; 174(5):1749-53. PubMed ID: 16217276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interpreting incidence trends for treated end-stage renal disease: implications for evaluating disease control in Australia.
    Stewart JH; McCredie MR; Williams SM; McDonald SP
    Nephrology (Carlton); 2004 Aug; 9(4):238-46. PubMed ID: 15363056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. End-stage renal failure due to analgesic nephropathy, its changing pattern and cardiovascular mortality. EDTA-ERA Registry Committee.
    Brunner FP; Selwood NH
    Nephrol Dial Transplant; 1994; 9(10):1371-6. PubMed ID: 7816247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increases in renal replacement therapy in Australia and New Zealand: understanding trends in diabetic nephropathy.
    Grace BS; Clayton P; McDonald SP
    Nephrology (Carlton); 2012 Jan; 17(1):76-84. PubMed ID: 21854505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Divergent trends in the incidence of end-stage renal disease due to Type 1 and Type 2 diabetes in Europe, Canada and Australia during 1998-2002.
    ; Stewart JH; McCredie MR; Williams SM
    Diabet Med; 2006 Dec; 23(12):1364-9. PubMed ID: 17116189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unchanged incidence of diabetic nephropathy in Type 1 diabetes: a nation-wide study in Iceland.
    Tryggvason G; Indridason OS; Thorsson AV; Hreidarsson AB; Palsson R
    Diabet Med; 2005 Feb; 22(2):182-7. PubMed ID: 15660736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetic nephropathy as a cause of end-stage renal disease in Egypt: a six-year study.
    Afifi A; El Setouhy M; El Sharkawy M; Ali M; Ahmed H; El-Menshawy O; Masoud W
    East Mediterr Health J; 2004; 10(4-5):620-6. PubMed ID: 16335654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time trends in the epidemiology of renal transplant patients with type 1 diabetes mellitus over the last four decades.
    Cao C; Hellermann JP; Weber M; Ambühl PM
    Nephrol Dial Transplant; 2006 Mar; 21(3):770-5. PubMed ID: 16401627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of withdrawal of phenacetin-containing analgesics on the incidence of kidney and urothelial cancer and renal failure.
    McCredie M; Stewart JH; Mathew TH; Disney AP; Ford JM
    Clin Nephrol; 1989 Jan; 31(1):35-9. PubMed ID: 2783667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. End-stage renal disease among the Zuni Indians: 1973-1983.
    Pasinski R; Pasinski M
    Arch Intern Med; 1987 Jun; 147(6):1093-6. PubMed ID: 3592874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of the survival of permanent vascular access ports].
    Rodríguez JA; Ferrer E; Olmos A; Codina S; Borrellas J; Piera L
    Nefrologia; 2001; 21(3):260-73. PubMed ID: 11471307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The descriptive epidemiology of patients with kidney failure on chronic dialysis treatment. The results of the Lazio Population Registry. The Lazio Dialysis Registry].
    Di Lallo D; Miceli M; Perucci CA
    Epidemiol Prev; 1997; 21(3):194-201. PubMed ID: 9424436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different regional dynamics of end-stage renal disease in Japan by different causes.
    Kato N; Usami T; Fukuda M; Motokawa M; Kamiya Y; Yoshida A; Kimura G
    Nephrology (Carlton); 2005 Aug; 10(4):400-4. PubMed ID: 16109089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.